144 related articles for article (PubMed ID: 7645607)
21. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
22. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
[TBL] [Abstract][Full Text] [Related]
23. Genotype/phenotype correlations in Wilms' tumor.
Huff V
Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
[TBL] [Abstract][Full Text] [Related]
24. [Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].
Stallmach T; Neuhaus TJ; Kösters R; Hailemariam S
Pathologe; 1998 May; 19(3):230-4. PubMed ID: 9648150
[TBL] [Abstract][Full Text] [Related]
25. Denys-Drash syndrome with neonatal renal failure in monozygotic twins due to c.1097G>A mutation in the WT1 gene.
Furtado LV; Pysher T; Opitz J; Lamb R; Comstock J; Batish S; Mauch T; Nelson R; Zhou H
Fetal Pediatr Pathol; 2011; 30(4):266-72. PubMed ID: 21434831
[TBL] [Abstract][Full Text] [Related]
26. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
27. Role of Wilms tumor 1 (WT1) in the transcriptional regulation of the Mullerian-inhibiting substance promoter.
Hossain A; Saunders GF
Biol Reprod; 2003 Dec; 69(6):1808-14. PubMed ID: 12855602
[TBL] [Abstract][Full Text] [Related]
28. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
Mrowka C; Schedl A
J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
[TBL] [Abstract][Full Text] [Related]
29. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
[TBL] [Abstract][Full Text] [Related]
30. Candidate genes for congenital diaphragmatic hernia from animal models: sequencing of FOG2 and PDGFRalpha reveals rare variants in diaphragmatic hernia patients.
Bleyl SB; Moshrefi A; Shaw GM; Saijoh Y; Schoenwolf GC; Pennacchio LA; Slavotinek AM
Eur J Hum Genet; 2007 Sep; 15(9):950-8. PubMed ID: 17568391
[TBL] [Abstract][Full Text] [Related]
31. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms.
Klamt B; Koziell A; Poulat F; Wieacker P; Scambler P; Berta P; Gessler M
Hum Mol Genet; 1998 Apr; 7(4):709-14. PubMed ID: 9499425
[TBL] [Abstract][Full Text] [Related]
32. No evidence of WT1 gene mutations in children with congenital diaphragmatic hernia.
Nordenskjöld A; Tapper-Persson M; Anvret M
J Pediatr Surg; 1996 Jul; 31(7):925-7. PubMed ID: 8811558
[TBL] [Abstract][Full Text] [Related]
33. A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome.
Tsuda M; Sakiyama T; Owada M; Chiba Y
Acta Paediatr Jpn; 1996 Jun; 38(3):265-6. PubMed ID: 8741319
[TBL] [Abstract][Full Text] [Related]
34. Hydrothorax in a patient with Denys-Drash syndrome associated with a diaphragmatic defect.
Cho HY; Lee BS; Kang CH; Kim WH; Ha IS; Cheong HI; Choi Y
Pediatr Nephrol; 2006 Dec; 21(12):1909-12. PubMed ID: 16932893
[TBL] [Abstract][Full Text] [Related]
35. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
Nordenskjöld A; Friedman E; Anvret M
Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
[TBL] [Abstract][Full Text] [Related]
36. Denys-Drash syndrome.
Kucinskas L; Rudaitis S; Pundziene B; Just W
Medicina (Kaunas); 2005; 41(2):132-4. PubMed ID: 15758579
[TBL] [Abstract][Full Text] [Related]
37. Association of partial gonadal dysgenesis, nephropathy and WT1 gene mutation without Wilms' tumor: incomplete Denys-Drash syndrome.
Cetinkaya E; Ocal G; Berberoğlu M; Adiyaman P; Ekim M; Yalçinkaya F; Orün E
J Pediatr Endocrinol Metab; 2001 May; 14(5):561-4. PubMed ID: 11393579
[TBL] [Abstract][Full Text] [Related]
38. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion.
Little MH; Williamson KA; Mannens M; Kelsey A; Gosden C; Hastie ND; van Heyningen V
Hum Mol Genet; 1993 Mar; 2(3):259-64. PubMed ID: 8388765
[TBL] [Abstract][Full Text] [Related]
39. Distinct molecular origins for Denys-Drash and Frasier syndromes.
Poulat F; Morin D; König A; Brun P; Giltay J; Sultan C; Dumas R; Gessler M; Berta P
Hum Genet; 1993 Apr; 91(3):285-6. PubMed ID: 8386697
[TBL] [Abstract][Full Text] [Related]
40. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.
Patek CE; Little MH; Fleming S; Miles C; Charlieu JP; Clarke AR; Miyagawa K; Christie S; Doig J; Harrison DJ; Porteous DJ; Brookes AJ; Hooper ML; Hastie ND
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2931-6. PubMed ID: 10077614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]